Market Cap

Calliditas Therapeutics AB Market Capitalization:

kr11.03 Billion

SEK as of July 1, 2024

US$1.04 Billion

business Calliditas Therapeutics AB Company Profile

Calliditas Therapeutics AB Main Stock Listing

OMX: CALTX

Market Capitalization History of Calliditas Therapeutics AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Calliditas Therapeutics AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr6.82 B 20.49%
Jan. 1, 2023 kr5.66 B 7.49%
Jan. 1, 2022 kr5.27 B -16.52%
Jan. 1, 2021 kr6.31 B 2.46%
Jan. 1, 2020 kr6.16 B 171.43%
Jan. 1, 2019 kr2.27 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Calliditas Therapeutics AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Calliditas Therapeutics AB has the following listings and related stock indices.


Stock: OMX: CALTX

Stock: FSX: LC8A

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.